Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use
United States Food and Drug Administration
Indexed incrossref
Abstract
Background
Vitamin C at high concentrations is toxic to cancer cells in vitro. Early clinical studies of vitamin C in patients with terminal cancer suggested clinical benefit, but 2 double-blind, placebo-controlled trials showed none. However, these studies used different routes of administration.
Objective
To determine whether plasma vitamin C concentrations vary substantially with the route of administration.
Citation impact
966
total citations
- FWCI
- 12.89
- Percentile
- 100%
- References
- 22
Citations per year
Authors
8- SJSebastian J. PadayattyCorresponding
United States Food and Drug Administration
- HSHe Sun
United States Food and Drug Administration
- YWYaohui Wang
United States Food and Drug Administration
- HDHugh D. Riordan
United States Food and Drug Administration
- SMStephen M. Hewitt
United States Food and Drug Administration
Topics & keywords
Topics
Keywords
- Medicine
- Pharmacokinetics
- Oral administration
- Vitamin
- Urine
- Placebo
- Pharmacology
- Route of administration
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.